The role of lncRNA MALAT1 in bone metastasis in patients with non-small cell lung cancer.

Abstract:

:lncRNA metastasis-associated lung adencarcinoma transcript 1 (MALAT1) plays an important role in the metastasis of lung cancer. Yet, its role in bone metastasis and the related mechanism remain unknown. The present study aimed to investigate the role of lncRNA MALAT1 in the bone metastasis of non-small cell lung cancer (NSCLC), including the expression pattern in tumor tissues, and the effect on the apoptosis, proliferation, migration and invasion of NSCLC cells. The expression level of MALAT1 in NSCLC tissues with/without bone metastasis and in NSCLC cell lines with (ACC-LC-319/bone2)/without (SPC‑A1) bone metastatic ability was determined with qRT-PCR and compared with t-test. si-MALAT1 was used to downregulate the expression of MALAT1 in ACC-LC-319/bone2 cells. The proliferation ability was assessed by MTT assay, and the apoptosis, migration, invasion and tumorigenesis in vivo were also assessed to detect the effect of MALAT1 expression on NSCLC cells. In conclusion, the present study found that MALAT1 was significantly highly expressed in NSCLC tissues with bone metastasis and in NSCLC cell lines with high bone metastatic ability (P<0.0001). Downregulation of MALAT1 expression significantly inhibited proliferation and induced cell apoptosis in comparing with the negative controls. Our results also revealed that MALAT1 significantly increased the migration, invasion and tumorigenesis in vivo, which suggests its important role in the bone metastasis of NSCLC.

journal_name

Oncol Rep

journal_title

Oncology reports

authors

Liu M,Sun W,Liu Y,Dong X

doi

10.3892/or.2016.4909

subject

Has Abstract

pub_date

2016-09-01 00:00:00

pages

1679-85

issue

3

eissn

1021-335X

issn

1791-2431

journal_volume

36

pub_type

杂志文章
  • Expression of angiogenic markers in the peripheral blood of docetaxel-treated advanced breast cancer patients: a Hellenic Cooperative Oncology Group (HeCOG) study.

    abstract::It is well known that low-dose metronomic chemotherapy has antiangiogenic activity. The aim of the present trial was to investigate the antiangiogenic properties of weekly docetaxel in patients with metastatic breast cancer. In total, 157 metastatic breast cancer patients received 3...

    journal_title:Oncology reports

    pub_type: 临床试验,杂志文章

    doi:10.3892/or.2011.1504

    authors: Pectasides D,Papaxoinis G,Kotoula V,Fountzilas H,Korantzis I,Koutras A,Dimopoulos AM,Papakostas P,Aravantinos G,Varthalitis I,Kosmidis P,Skarlos D,Bournakis E,Bafaloukos D,Kalofonos HP,Kalogeras KT,Fountzilas G

    更新日期:2012-01-01 00:00:00

  • Chemoradiotherapy and concurrent radiofrequency thermal therapy to treat primary rectal cancer and prediction of treatment responses.

    abstract::The present study aimed to evaluate a previously reported predictive formula of output-limiting symptoms induced by radiofrequency (RF) to determine the efficacy of this neoadjuvant chemoradiation (NACR) and concurrent RF thermal therapy. The present study included 81 consecutive patients with confirmed diagnoses of r...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2016.5300

    authors: Shoji H,Motegi M,Takakusagi Y,Asao T,Kuwano H,Takahashi T,Ogoshi K

    更新日期:2017-02-01 00:00:00

  • A novel region of deletion on 13q33-q34 in esophageal squamous cell carcinoma.

    abstract::Chromosome 13 presents frequent allelic loss in esophageal squamous cell carcinomas (ESCC). However, no ESCC suppressor gene has been identified from this chromosome. To define common deletion regions that possibly contain the ESCC suppressor gene(s), we performed a mapping of allelic loss in 50 esophageal squamous ce...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Guo GM,Huang XP,Dong JT,Caia Y,Xu X,Han YL,Wu M,Zhan QM,Wang MR

    更新日期:2005-12-01 00:00:00

  • Pathotropic targeting advances clinical oncology: tumor-targeted localization of therapeutic gene delivery.

    abstract::The advent of pathotropic (disease-seeking) targeting has transported genetic medicine across the threshold of history with the progressive clinical validation of Rexin-G, a tumor-targeted nanosized anti-cancer agent. Achieving noteworthy single-agent efficacy and survival benefits in otherwise intractable cancers, th...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2010.829

    authors: Hall FL,Levy JP,Reed RA,Petchpud WN,Chua VS,Chawla SP,Gordon EM

    更新日期:2010-10-01 00:00:00

  • Estimating subthreshold tumor on MRI using a 3D-DTI growth model for GBM: An adjunct to radiation therapy planning.

    abstract::Mathematical modeling and serial magnetic resonance imaging (MRI) used to calculate patient-specific rates of tumor diffusion, D, and proliferation, ρ, can be combined to simulate glioblastoma multiforme (GBM) growth. We showed that the proportion and distribution of tumor cells below the MRI threshold are determined ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2016.4878

    authors: Hathout L,Patel V

    更新日期:2016-08-01 00:00:00

  • [Corrigendum] A 19‑miRNA Support Vector Machine classifier and a 6‑miRNA risk score system designed for ovarian cancer patients.

    abstract::Subsequently to the publication of this paper, the authors have realized that the affilitation address omitted the name of the university at which this research was conducted (Capital Medical University). Therefore, the author affiliations for this paper should have appeared as follows (changes are highlighted in bold...

    journal_title:Oncology reports

    pub_type: 杂志文章,已发布勘误

    doi:10.3892/or.2019.7385

    authors: Dong J,Xu M

    更新日期:2019-12-01 00:00:00

  • Ascorbate (vitamin C) induces cell death through the apoptosis-inducing factor in human breast cancer cells.

    abstract::Although ascorbate (Vitamin C) has been shown to inhibit cell growth and induce cell death in variety of cancer cells, results reported in other studies are inconsistent with this conclusion. It was previously reported that ascorbate induces apoptosis in human breast cancer cells. However, the molecular mechanism for ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Hong SW,Jin DH,Hahm ES,Yim SH,Lim JS,Kim KI,Yang Y,Lee SS,Kang JS,Lee WJ,Lee WK,Lee MS

    更新日期:2007-10-01 00:00:00

  • Histone deacetylase 4 increases progressive epithelial ovarian cancer cells via repression of p21 on fibrillar collagen matrices.

    abstract::Histone deacetylase (HDAC) 4 is an emerging target in cancer therapeutics, but little is known about the function of HDAC4 in gynecologic malignancies. Therefore we investigated the mechanism of HDAC4 promoting the proliferation of epithelial ovarian cancer cells (OV). In this study, we observed that the proliferation...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2015.4423

    authors: Shen YF,Wei AM,Kou Q,Zhu QY,Zhang L

    更新日期:2016-02-01 00:00:00

  • Autophagy in human skin squamous cell carcinoma: Inhibition by 3-MA enhances the effect of 5-FU-induced chemotherapy sensitivity.

    abstract::Autophagy is an intracellular multi-step catabolic degradation process that involves the degradation and recycling of cellular proteins and cytoplasmic damaged organelles to maintain cellular homeostasis and reduction of metabolic stress. Numerous studies have indicated the importance of autophagy in cancer, but the r...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2015.4302

    authors: Zhang L,Zhang J,Chen L,Wang J

    更新日期:2015-12-01 00:00:00

  • Expression of DNA mismatch repair proteins hMSH2 and hMLH1 and the cyclin G1 inhibitor, p21(waf1/cip1) in pediatric tumors: correlation with response to therapy.

    abstract::The expression of the DNA mismatch repair proteins hMSH2 and hMLH1 and p21(waf1) the cyclin G1 inhibitor, may determine response of adult cancers to anti-cancer drugs, that include alkylating agents and platinum-based drugs. The role of DNA mismatch repair proteins (hMSH2 and hMLH1) and p21(waf1) in pediatric tumor re...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.8.5.965

    authors: Idikio HA

    更新日期:2001-09-01 00:00:00

  • WT1 regulates cyclin A1 expression in K562 cells.

    abstract::The restricted expression of Wilms tumor 1 (WT1) and cyclin A1 (CCNA1) in normal tissues, as opposed to their abnormal expression in leukemia demonstrates the applicability of WT1 and CCNA1 as cancer antigens for immunotherapy, and as markers for prognosis and relapse. In this study, the WT1 and CCNA1 mRNA levels were...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2019.7287

    authors: Pandey S,Moazam M,Ghimirey N,Kuerbitz SJ,Fraizer GC

    更新日期:2019-11-01 00:00:00

  • NRF2 is overexpressed in ovarian epithelial carcinoma and is regulated by gonadotrophin and sex-steroid hormones.

    abstract::Aberrant nuclear factor-erythroid 2 (NRF2) expression correlates with tumor development. We investigated NRF2 expression in ovarian epithelial carcinoma (OEC), aiming to identify associations with clinicopathological factors, hormones and induced reactive oxygen species (ROS). Immun...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2012.1700

    authors: Liao H,Zhou Q,Zhang Z,Wang Q,Sun Y,Yi X,Feng Y

    更新日期:2012-06-01 00:00:00

  • Inhibition of NADPH oxidase activity promotes differentiation of B16 melanoma cells.

    abstract::The activity of NADPH oxidase is increased in malignant skin keratinocytes. We demonstrated that inhibition of NADPH oxidase activity by diphenyleneiodonium (DPI) suppressed free radical production, inhibited cell growth and promoted cell differentiation of B16 melanoma cells, as indicated by cell morphology, increase...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Zhao Y,Liu J,McMartin KE

    更新日期:2008-05-01 00:00:00

  • Glutathione and glutathione peroxidase expression in breast cancer: an immunohistochemical and molecular study.

    abstract::The use of prognostic markers for breast cancer allows therapeutic strategies to be defined more efficiently. The expression of glutathione (GSH) and glutathione peroxidase (GPX) in tumor cells has been evaluated as a predictor of prognosis and response to cytotoxic treatments. Its immunoexpression was assessed in 63 ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2013.2540

    authors: Jardim BV,Moschetta MG,Leonel C,Gelaleti GB,Regiani VR,Ferreira LC,Lopes JR,Zuccari DA

    更新日期:2013-09-01 00:00:00

  • The novel herbal cocktail MA128 suppresses tumor growth and the metastatic potential of highly malignant tumor cells.

    abstract::MA128, a novel herbal medicine, was previously identified and its effectiveness in the treatment of asthma and atopic dermatitis (AD) was demonstrated. In particular, post-inflammatory hyperpigmentation (PIH) in AD mice was improved by treatment with MA128. In addition, MA128 exhibited anti-melanogenic activity by inh...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2015.4018

    authors: Kim A,Im M,Yim NH,Hwang YH,Yang HJ,Ma JY

    更新日期:2015-08-01 00:00:00

  • Classification of neural differentiation-associated genes in P19 embryonal carcinoma cells by their expression patterns induced after cell aggregation and/or retinoic acid treatment.

    abstract::Expression of neural differentiation-associated genes was examined by RT-PCR and macroarray analyses during neural differentiation of P19 embryonal carcinoma cells induced by cell aggregation and/or retinoic acid (RA) treatment. Results revealed that the neural genes examined could be classified into 4 groups based on...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Teramoto S,Kihara-Negishi F,Sakurai T,Yamada T,Hashimoto-Tamaoki T,Tamura S,Kohno S,Oikawa T

    更新日期:2005-11-01 00:00:00

  • Overexpression of Id-1 protein is a marker in colorectal cancer progression.

    abstract::The inhibitor of differentiation/DNA binding 1 (Id-1), a negative regulator of basic helix-loop-helix transcription factors, plays an important role in the regulation of cell proliferation and differentiation. We examined the Id-1 expression by immunohistochemistry in 9 adenomas, 79 primary colorectal adenocarcinomas ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Zhao ZR,Zhang ZY,Zhang H,Jiang L,Wang MW,Sun XF

    更新日期:2008-02-01 00:00:00

  • Oleanolic acid enhances the radiosensitivity of tumor cells under mimetic hypoxia through the reduction in intracellular GSH content and HIF-1α expression.

    abstract::We previously found that oleanolic acid (OA), a naturally pentacyclic triterpenoid, enhances the radiosensitizing effect on tumor cells. However, it is unclear whether or not OA enhances the radiosensitivity of hypoxic cells. Therefore, the aim of the present study was to further observe the influence of OA on hypoxic...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2014.3064

    authors: Qi R,Jin W,Wang J,Yi Q,Yu M,Xu S,Jin W

    更新日期:2014-05-01 00:00:00

  • Generation of reactive oxygen species mediates butein-induced apoptosis in neuroblastoma cells.

    abstract::Flavonoids exhibit chemopreventive and chemotherapeutic effects. Butein, a bioactive flavonoid isolated from numerous native plants, has been shown to induce apoptosis in human cancer cells. In the current study, the molecular mechanisms of butein action on cell proliferation and apoptosis of neuroblastoma cells were ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2012.1632

    authors: Chen YH,Yeh CW,Lo HC,Su SL,Hseu YC,Hsu LS

    更新日期:2012-04-01 00:00:00

  • Interference of STAT 5b expression enhances the chemo-sensitivity of gastric cancer cells to gefitinib by promoting mitochondrial pathway-mediated cell apoptosis.

    abstract::Signal transducer and activator of transcription (STAT) 5, including STAT 5a and STAT 5b, was reported to play important roles in the malignant biological behaviors of tumors. However, their roles in gastric cancer, especially for STAT 5b remain unknown. This study aimed to detect the expression of STAT 5b in gastric ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2015.3994

    authors: Sun T,Jia Y,Xiao D

    更新日期:2015-07-01 00:00:00

  • Spindle-cell ameloblastic carcinoma: A case report with immunohistochemical, ultrastructural, and comparative genomic hybridization analyses.

    abstract::Spindle-cell ameloblastic carcinoma is a classification proposed for a group of rare odontogenic carcinomas with sarcomatoid components and is distinguished from odontogenic carcinosarcoma. We report a case of spindle-cell ameloblastic carcinoma of the right mandible that occurred in a 67-year-old Japanese man. Growth...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Kawauchi S,Hayatsu Y,Takahashi M,Furuya T,Oga A,Niwa S,Sasaki K

    更新日期:2003-01-01 00:00:00

  • Siegesbeckia glabrescens induces apoptosis with different pathways in human MCF-7 and MDA-MB-231 breast carcinoma cells.

    abstract::Breast cancer is one of the most common malignancies diagnosed in women and it is increasing in incidence. Siegesbeckia glabrescens (SG) has been used in traditional oriental medicine to treat cardiovascular diseases such as hypertension and angina pectoris. This study examined whether or not SG could induce apoptosis...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Jun SY,Choi YH,Shin HM

    更新日期:2006-06-01 00:00:00

  • Antitumor and antiangiogenic activity of soy isoflavone genistein in mouse models of melanoma and breast cancer.

    abstract::Tumor invasion, angiogenesis and metastasis involve secretion of proteolytic enzymes and cell migration into blood vessels. Tumor cells are capable of degrading the extracellular matrix via a proteolytic cascade that includes urokinase-type plasminogen activator (uPA) and matrix metalloproteases (MMPs). We have invest...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Farina HG,Pomies M,Alonso DF,Gomez DE

    更新日期:2006-10-01 00:00:00

  • Fetal fibronectin: a new screening-marker for bladder cancer?

    abstract::Early detection of transitional cell carcinoma (TCC) of the urinary bladder is essential for effective treatment. While several serum markers have been evaluated, none have been widely accepted for practical clinical use. Thus, urinary markers have been introduced and investigated to detect the evidence of bladder can...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.8.3.669

    authors: Wunderlich H,Reichelt O,Zermann DH,Schubert J,Berndt A,Kosmehl H

    更新日期:2001-05-01 00:00:00

  • Overexpression of IC53d promotes the proliferation of gastric cancer cells by activating the AKT/GSK3β/cyclin D1 signaling pathway.

    abstract::Cyclin‑dependent kinase 5 regulatory subunit‑​associated protein 3 (CDK5RAP3 or C53) is involved in the development of various types of tumor, and alternative splicing of C53 results in numerous transcription variants that encode different isoforms. The present study aimed to clone human C53 isoform d (IC53d) and expl...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2019.7042

    authors: Lin JX,Xie XS,Weng XF,Qiu SL,Xie JW,Wang JB,Lu J,Chen QY,Cao LL,Lin M,Tu RH,Li P,Huang CM,Zheng CH

    更新日期:2019-05-01 00:00:00

  • Induction and mechanism of HeLa cell apoptosis by 9-oxo‑10, 11-dehydroageraphorone from Eupatorium adenophorum.

    abstract::9-Oxo-10, 11-dehydroageraphorone (euptox A), a cadenine sesquiterpene, is the main toxin from Eupatorium adenophorum. The aim of the present study was to examine the induction and mechanism of HeLa cell apoptosis by euptox A. The apoptosis‑inducing effect of the euptox A on HeLa cells was examined by MTT assay. The un...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2015.3778

    authors: Liao F,Hu Y,Wu L,Tan H,Luo B,He Y,Qiao Y,Mo Q,Wang Y,Zuo Z,Deng J,Wei Y

    更新日期:2015-04-01 00:00:00

  • GLIS2 redundancy causes chemoresistance and poor prognosis of gastric cancer based on co‑expression network analysis.

    abstract::Gastric cancer is currently the fourth most common cancer and the third leading cause of cancer‑associated mortality worldwide. Studies have identified that certain biomarkers contribute to the prognosis, diagnosis and treatment of gastric cancer. However, the biomarkers of gastric cancer are rarely used clinically. T...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2018.6794

    authors: Yuan J,Tan L,Yin Z,Tao K,Wang G,Shi W,Gao J

    更新日期:2019-01-01 00:00:00

  • Inhibition of pancreatic cancer and potentiation of gemcitabine effects by the extract of Pao Pereira.

    abstract::Lack of effective therapy is a major problem in the treatment of pancreatic cancer. In the present study, we investigated a natural product, the extract of Pao Pereira (Pao), for its anti-pancreatic cancer effect in vitro and in vivo, either alone or in combination with the first-line chemotherapeutic drug gemcitabine...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2013.2461

    authors: Yu J,Drisko J,Chen Q

    更新日期:2013-07-01 00:00:00

  • Acylated and unacylated ghrelin inhibit apoptosis in myoblasts cocultured with colon carcinoma cells.

    abstract::Cancer cachexia is a life‑threatening syndrome associated with myofiber damage. Tumor factors impair muscle regeneration by promoting myoblast apoptosis. Ghrelin is a multifunctional hormone with an anti‑apoptotic effect, but its mechanism of action is not fully understood. In the present study, we investigated whethe...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2018.6213

    authors: Zeng X,Chen S,Lin Y,Ke Z

    更新日期:2018-03-01 00:00:00

  • Autocrine interferon-γ may affect malignant behavior and sensitivity to tamoxifen of MCF-7 via estrogen receptor β subtype.

    abstract::Mitogenic actions of estrogens are mediated by two distinct estrogen receptors (ERs), which are critical in the progression and therapeutic response of breast cancer. ER expression is a dynamic phenomenon that is regulated by numerous factors, including cytokines, in the tumor microenvironment. Recently, studies have ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2015.4294

    authors: Niu XL,Wang Y,Yao Z,Duan H,Li Z,Liu W,Zhang H,Deng WM

    更新日期:2015-12-01 00:00:00